Published in Hum Vaccin Immunother on July 22, 2013
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
Botulinum toxin as a biological weapon: medical and public health management. JAMA (2001) 9.18
Human botulism immune globulin for the treatment of infant botulism. N Engl J Med (2006) 5.67
Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 5.30
DNA vaccines: ready for prime time? Nat Rev Genet (2008) 4.10
Passive antibody therapy for infectious diseases. Nat Rev Microbiol (2004) 2.64
Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol (2011) 2.25
DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer (2008) 2.23
Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem Sci (2002) 1.85
Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine (2004) 1.74
Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci (1999) 1.39
Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route. Infect Immun (2007) 1.37
Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA (2006) 1.14
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain. PLoS One (2008) 1.11
Recombinant holotoxoid vaccine against botulism. Infect Immun (2007) 1.09
Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies. FEBS Lett (2004) 1.07
Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine. Vaccine (2007) 1.04
The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. J Infect Dis (2011) 1.02
In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine (2004) 0.98
Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system. Clin Vaccine Immunol (2010) 0.97
Type C botulism due to toxic feed affecting 52,000 farmed foxes and minks in Finland. J Clin Microbiol (2004) 0.97
Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity. PLoS One (2010) 0.97
Vaccines against botulism. Curr Opin Microbiol (2012) 0.96
DNA vaccines for targeting bacterial infections. Expert Rev Vaccines (2010) 0.92
Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A. Vaccine (2007) 0.92
DNA vaccination protects against botulinum neurotoxin type F. Vaccine (2003) 0.92
Botulinum toxin: from life-threatening disease to novel medical therapy. Am J Obstet Gynecol (2007) 0.88
Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer. Infect Immun (2009) 0.87
Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells. Infect Immun (2011) 0.87
Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology. Adv Drug Deliv Rev (2005) 0.86
Production and characterisation of a neutralising chimeric antibody against botulinum neurotoxin A. PLoS One (2010) 0.85
Botulinum toxin: application, safety, and limitations. Curr Top Microbiol Immunol (2013) 0.85
Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review. Transplant Proc (2011) 0.85
Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid. Vaccine (2002) 0.85
Genetic immunization with plasmid DNA mediated by electrotransfer. Hum Gene Ther (2011) 0.84
Potent antirheumatic activity of a new DNA vaccine targeted to B7-2/CD28 costimulatory signaling pathway in autoimmune arthritis. Hum Gene Ther (2010) 0.82
Subunit vaccine efficacy against Botulinum neurotoxin subtypes. Vaccine (2011) 0.81
Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B. Clin Vaccine Immunol (2010) 0.81
DNA vaccines for the prevention and treatment of allergy. Curr Opin Allergy Clin Immunol (2009) 0.80
Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system. J Virol Methods (2013) 0.79
Sheep monoclonal antibodies prevent systemic effects of botulinum neurotoxin A1. Toxins (Basel) (2012) 0.78